Quantcast
Channel: メディカルプレスセンター QLifePro »遺伝学
Browsing all 1368 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Biogen Idec to Present Data from Hematology Programs, Including ELOCTATE™ and...

  CAMBRIDGE, Mass. Biogen Idec (NASDAQ: BIIB) will present data supporting its approved hemophilia therapies at the 56th Annual Meeting of the American Society of Hematology (ASH) taking place in San...

View Article


Image may be NSFW.
Clik here to view.

Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from...

  SAN FRANCISCO Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today reported data demonstrating that Hodgkin lymphoma (HL) patients at risk of relapse...

View Article


Image may be NSFW.
Clik here to view.

Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS®...

  SAN FRANCISCO Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced four-year overall survival (OS) data from the ADCETRIS (brentuximab vedotin)...

View Article

Image may be NSFW.
Clik here to view.

Seattle Genetics和武田在ASH年会上报告ADCETRIS® (Brentuximab...

  旧金山 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq: SGEN)与武田药品工业株式会社(TSE:4502)今天报告的数据显示,自体干细胞移植(ASCT)后有复发风险的霍奇金淋巴瘤(HL)患者,在ASCT后立即接受ADCETRIS (brentuximab...

View Article

Image may be NSFW.
Clik here to view.

Seattle Genetics和武田在ASH年会上发布ADCETRIS® (Brentuximab...

  旧金山 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq: SGEN)与武田药品工业株式会社 (TSE:4502)今天发布了ADCETRIS (brentuximab vedotin)治疗复发或难治全身性间变性大细胞淋巴瘤(ALCL)枢纽性2期临床试验的4年总生存(OS)数据。ADCETRIS是一种靶向作用于CD30的抗体药物轭合物...

View Article


Image may be NSFW.
Clik here to view.

Macrogen to Supply ‘X-Genome’ Genome Analysis Service to Institute of...

  SEOUL, South Korea Customized medicine & biotechnology company Macrogen Inc. (CEO HyungTae Kim, www.macrogen.com) announced that it has made an agreement to supply the company’s X-Genome...

View Article

Image may be NSFW.
Clik here to view.

CBI Pharma to Hold 6th Annual IVD Summit 2015 on March 12-13 in Shenzhen, China

  SHANGHAI CBI Pharma, a subsidiary of ENMORE, will hold the 6th Annual IVD Summit 2015 (IVDS 2015) in Shenzhen, China on March 12-13, 2015. As the No.1 IVD industry summit in China, IVDS discusses...

View Article

Image may be NSFW.
Clik here to view.

PreAnalytiX GmbH, NuGEN Technologies and RUCDR Infinite Biologics Partner to...

  HOMBRECHTIKON, Switzerland & SAN CARLOS, Calif. & PISCATAWAY, N.J. PreAnalytiX GmbH, NuGEN Technologies, Inc. and RUCDR Infinite Biologics (RUCDR), today announced a joint project to...

View Article


Image may be NSFW.
Clik here to view.

Promega PowerPlex® Fusion 6C System Improves Mixture Interpretation with...

  MADISON, Wis. Promega Corporation announces the release of the PowerPlex® Fusion 6C System, a 6-color, 27-locus multiplex. The system combines common and informative loci to overcome typical...

View Article


Image may be NSFW.
Clik here to view.

WaVe Life Sciences Closes $18 Million Series A Financing to Advance...

  BOSTON & OKINAWA, Japan WaVe Life Sciences today announced that it closed an $18 million Series A financing, led by RA Capital Management, LLC and Kagoshima Shinsangyo Sosei Investment LP,...

View Article

Image may be NSFW.
Clik here to view.

Life Sciences Hiring Index Posts Slight Decline to End Record Year

  WEST ORANGE, N.J. ZRG Partners, Inc. has announced the final findings for 2014 with their fourth quarter Global Life Sciences Hiring Index. Despite a small drop from Q3, 2014 ended with the highest...

View Article

Image may be NSFW.
Clik here to view.

Rosetta Genomics Receives First Patent Allowance in Japan

  PRINCETON, N.J. & REHOVOT, Israel Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company received a Notice of...

View Article

Image may be NSFW.
Clik here to view.

Labcyte Commends Institute for Molecular Medicine Finland – Pfizer Leukemia...

  SUNNYVALE, Calif. Labcyte, a company revolutionizing life science research with its patented acoustic liquid handling technology, today praised the results of an international collaboration between...

View Article


Image may be NSFW.
Clik here to view.

New Promega Reagent and Software Tool Monitors Performance of Mass...

  MADISON, Wis. Promega Corporation announces the release of the 6 × 5 LC-MS/MS Peptide Reference Mix, a novel reagent and software combination. The reagent monitors LC and MS parameters, while the...

View Article

Image may be NSFW.
Clik here to view.

WaVe Life Sciencesが立体化学的に純粋な核酸医薬品を前進させるための1800万ドルのシリーズA資金調達を完了

  ボストン & 沖縄 (ビジネスワイヤ) – WaVe Life Sciencesは 本日、当初からの出資企業SNBL Ltd.に加え、RA Capital Management, LLCとかごしま新産業創生投資事業有限責任組合が主導した1800万ドルのシリーズA資金調達を完了したと発表しました。調達した資金は、アンチセンス 医薬品およびエキソンスキッピング医薬品など...

View Article


Image may be NSFW.
Clik here to view.

Eppendorf发布新款CryoCube®超低温冰箱

  康涅狄格州恩菲尔德 –(美国商业资讯)–新款CryoCube F570、F570h、FC660和FC660h 超低温冰箱结合了最高的样品安全性和改进的功能性。新改进降低了能耗,使CryoCube 冰箱成为业界能效最高的产品。 CryoCube® F570h, F570, and FC660h Ultra-Low Temperature Freezers from Eppendorf....

View Article

Image may be NSFW.
Clik here to view.

エッペンドルフが新しいCryoCube®極低温冷凍庫を発表

  米コネティカット州エンフィールド (ビジネスワイヤ) — 新しい極低温冷凍庫のCryoCube F570、F570h、FC660、FC660hは、最高度の試料安全性、そして機能改善を実現しています。新たな技術進歩によって消費電力が減少し、CryoCubeは業界で最もエネルギー効率の高い冷凍庫となっています。 CryoCube® F570h, F570, and FC660h Ultra-Low...

View Article


Image may be NSFW.
Clik here to view.

Mitobridge Secures Key Intellectual Property from the Salk Institute

  CAMBRIDGE, Mass. Mitobridge, Inc., previously known as Mitokyne, Inc., a biopharmaceutical company pioneering the discovery and development of products that improve mitochondrial function, today...

View Article

Image may be NSFW.
Clik here to view.

DNAnexus Platform Powers Garvan Institute’s Move to Provide Global Genomic...

  MOUNTAIN VIEW, Calif. DNAnexus Inc., a pioneer in cloud-based genome informatics and data management, today announced that the Garvan Institute of Medical Research in Sydney, Australia is now using...

View Article

Image may be NSFW.
Clik here to view.

Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results...

  CAMBRIDGE, Mass. & STOCKHOLM Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today announced positive top-line results of the Kids B-LONG Phase 3 clinical...

View Article
Browsing all 1368 articles
Browse latest View live